| Name | Title | Contact Details |
|---|
Becker Orthopedic was founded in 1933 by Otto K. Becker to provide high quality orthotic components and central fabrication services. Today, Becker Orthopedic remains a family business dedicated to quality, service, and innovation in the field of
Merit Medical Systems, Inc is a leading manufacturer of medical devices used in diagnostic and interventional cardiology and radiology procedures. Its primary products consist of inflation devices used in angioplasty, stent placement and discography; diagnostic and therapeutic catheters used for various procedures in cardiology and radiology; guide wires used to place balloon angioplasty catheters within a patient`s coronary arteries; products used to manage and monitor the administration of contrast and other fluid solutions during diagnostic and therapeutic procedures; thrombolytic catheters and fluid dispensing systems; angiography accessories; and standard and custom angiography kits. Headquartered in South Jordan, Utah, a suburb of Salt Lake City, Merit employs approximately 1,900 people worldwide. Merit markets its products in the United States and Europe (direct sales force) and the world (distributors). They call directly on physicians and clinicians in hospitals and clinics worldwide. The Company has expanded to three separate facilities in the Salt Lake City, Utah area (South Jordan, Murray and West Jordan). Merit also has facilities in Galway, Ireland (guidewires), Angleton, Texas (catheters), in Richmond, Virginia (procedural trays and packs) and a customer service and distribution center in Maastricht, The Netherlands. The Company has achieved a world leadership position in inflation devices and hemostasis valves and is renowned for its product innovation, customer service and product quality. Merit possesses a proprietary manufacturing process which allows it to offer contract manufacturing (OEM) to a wide range of medical device companies. Merit Endotek is a newly created division of Merit. These products are focused in the gastroenterology medical device market. The products include stent technology in the emerging field of non-vascular interventional stenting. This next-generation stent technology is used in the lungs, esophagus, and biliary tract.
Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company`s mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system. ACT`s technology is the only system in the world to leverage feedback from four unique capabilities: temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing. The ACT system is not currently approved for commercial use.
Advanced Tissue is a Little Rock, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.